Skip to main content
. 2023 Jun 30;38(5):297–328. doi: 10.1097/YIC.0000000000000488

Fig. 2.

Fig. 2

Description of adverse events of novel antidepressant drugs. Common adverse events were defined as those having a frequency ≥5%, while rare adverse events as those with a frequency <5%. Serious adverse events are defined as any adverse event causing clinically significant disability and incapacity or immediately life-threatening. BUP, bupropion; DXM, dextromethorphan; NMDAR, n-methyl-d-aspartate receptor; OX-2R, orexin type 2 receptor; R, receptor.